Imaging study for people with liver cirrhosis
Part of Brain & nervous system, Digestive system clinical trials.
This study looks at how liver cirrhosis shows up on non-invasive imaging like CT scans, and how those findings relate to outcomes. It may help researchers better understand what scan patterns could signal disease severity.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with liver cirrhosis (from any cause)
- You have a CT scan available to share
- You do not have liver cancer (hepatocellular carcinoma)
- You do not have any other cancer or malignant disease
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a special ultrasound scan using contrast dye can better detect early liver cancer in people with cirrhosis (scarring of the liver). The goal is to catch liver cancer at an earlier, more treatable stage.
This study uses artificial intelligence to analyze CT scans before and during liver surgery. It aims to build a decision-making system to help doctors better plan and perform surgery for liver cancer or other growths.
This trial studies “focal liver lesions,” meaning specific spots in the liver, using a non-invasive (no surgery or biopsy) approach. It may help doctors better understand what these spots are in people who have cirrhosis.
This study looks at how well imaging predicts the outcome of surgery for liver metastases from colorectal or breast cancer. If you are having surgery to remove liver metastases, you may be able to participate.
This study tests whether a new type of MRI scan can better detect and measure liver disease, including fatty liver and scarring, compared to standard CT scans. If you have chronic liver disease, this study may help improve how we diagnose and track it.
This study follows people with cirrhosis to see how best to detect liver cancer early. If you qualify, you may receive regular monitoring that could help find liver cancer sooner, when treatment is more likely to work.
Hear when a new Liver Cirrhosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.